search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Decontamination chemistry Studies have shown that even when


reprocessing guidelines are followed, residual biofilms may persist, particularly when chemical exposure is inconsistent or insufficiently controlled. In many cases, the issue is not the inherent antimicrobial potential of the chemistry used, but the difficulty of ensuring that the active agent is present at the right concentration, for the right duration, and at the precise location required.4,7 This has prompted interest in oxidising agents capable of disrupting biofilm matrices as well as inactivating microorganisms. However, such agents have historically been challenging to deploy safely and consistently, limiting their adoption in routine clinical settings.8,9


The role of controlled chemistry in decontamination One emerging approach involves shifting from pre-manufactured disinfectant solutions toward systems that generate active chemistry on demand, immediately prior to use. The underlying concept is straightforward: rather than storing unstable oxidants, a stable precursor solution is converted into the active species at the point of application through a controlled process.10,11 From an operational perspective, this offers several potential advantages. Freshly generated


solutions can reduce variability caused by degradation. On-demand generation can limit the need for high-concentration storage and associated safety controls. Perhaps most importantly, it allows chemistry to be integrated more tightly into clinical workflows, rather than treated as a separate supply chain function. Chlorine dioxide provides a useful example. It is a well-characterised oxidising agent with documented antimicrobial activity across a broad spectrum of organisms. Yet its use in healthcare has historically been constrained by challenges related to generation, handling, and stability. Controlled generation platforms aim to address these limitations by producing aqueous chlorine dioxide at defined concentrations only when needed.10,11 While such systems do not eliminate the need for regulatory oversight or validation, they do change the operational context in which chemistry is applied. Instead of relying on assumptions about storage conditions or shelf life, performance becomes a function of defined system parameters.


Efficiency, throughput, and operational resilience Beyond microbiological efficacy, controlled chemistry systems may offer benefits related


to efficiency and throughput. In high-volume environments, even small reductions in preparation time or rework can translate into meaningful capacity gains.5 On-demand generation reduces delays


associated with chemical preparation or replacement. Consistent output can reduce the need for repeat cleaning cycles caused by under-dosing or degraded solutions. In some settings, this may enable more predictable turnaround times for devices and rooms. Workforce considerations are equally important. Simplifying chemical handling and reducing reliance on concentrated products may lower training burden and exposure risk. This is particularly relevant as healthcare systems contend with staff turnover and skill mix challenges.6


Towards a national decontamination strategy At a system level, there is growing recognition that decontamination should be approached as a strategic function rather than a series of isolated tasks. A national decontamination strategy would prioritise standardisation, evidence-based selection of technologies, and integration across care pathways.1,2 Such a strategy would not mandate


Combined Calprotectin & Elastase


CALEX Patient Pack One Pack, One Tube, Two Tests


Streamlined workflow - pre-prepared, extracted samples ready for laboratory testing.


Patients can efficiently prepare their samples, freeing up valuable laboratory resources.


 Perform calprotectin and elastase from the same tube  Immediate stabilisation of the analytes  Up to 7 days ambient stability for sample return  Ready-to-run on receipt


 Survey demonstrated high patient acceptance and ease of use


 UKCA marked


Streamline Your Laboratory Processes Please Visit alphalabs.co.uk/calex-pack


Phone: 023 8048 3000 | Email: info@alphalabs.co.uk 05 CALEX 2 - CSJ - 125x180 - Sept 2026.indd 1 15/09/2026 16:53:34 November 2026 I www.clinicalservicesjournal.com 67


▲


NEW!


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71